Not applicableStudy completedNCT02966626What this trial is testingA Real World Experience of Dapagliflozin in Type 2 DiabetesWho this might be right forType2 Diabetes University of Malaya 223
Post-approval studies (Phase 4)Looking for participantsNCT06972732What this trial is testingA Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 DiabetesWho this might be right forType 2 Diabetes Boryung Pharmaceutical Co., Ltd 204
Post-approval studies (Phase 4)UnknownNCT03877406What this trial is testingEffect of Empagliflozin on Body Composition and KetonesWho this might be right forDiabetes MellitusFat; Intolerance, Pancreas Seoul National University Bundang Hospital 200
Testing effectiveness (Phase 2)Looking for participantsNCT06655480What this trial is testingTriple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEFWho this might be right forHFpEFLVDDMyocardial Fibrosis National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 50
Post-approval studies (Phase 4)UnknownNCT02577159What this trial is testingDapagliflozin on Hyperlipidemia and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study)Who this might be right forDiabetes Mellitus, Type 2 Osaka University 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05182658What this trial is testingEmpagliflozin in Hypertrophic CardiomyopathyWho this might be right forHypertrophic CardiomyopathyHeart Failure National Institute of Cardiology, Warsaw, Poland 250
Not applicableStudy completedNCT03473262What this trial is testingEmpagliflozin-based Quadruple Combination vs Insulin Glarine-based Combination Therapy in Patients With Type 2 DiabetesWho this might be right forDiabetes Mellitus, Type 2 Chungbuk National University Hospital 200
Post-approval studies (Phase 4)Looking for participantsNCT05612594What this trial is testingAdipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA StudyWho this might be right forSleep Apnea Yale University 164
Not applicableStudy completedNCT06453161What this trial is testingPre-operative Exposure to SGLT2 Inhibitors and Post-operative Acute Renal Failure in Cardiac Surgery: a Retrospective Monocentric Cohort StudyWho this might be right forAcute Kidney InjuryCardiacSurgery Hospices Civils de Lyon 500
Large-scale testing (Phase 3)Looking for participantsNCT05669742What this trial is testingEmpagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia PatientsWho this might be right forSodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics Tanta University 40
Post-approval studies (Phase 4)Active Not RecruitingNCT05590143What this trial is testingProMoting Effective Renoprotection in Cardiac sURgery Patients by Inhibition of SGLT-2Who this might be right forAcute Kidney InjuryCardiac SurgerySodium-Glucose Transporter 2 Inhibitor Amsterdam UMC 784
Post-approval studies (Phase 4)Study completedNCT05233163What this trial is testingSGLT2 Inhibitors in Transthyretin Amyloid CardiomyopathyWho this might be right forTransthyretin Amyloid Cardiomyopathy Columbia University 15
Large-scale testing (Phase 3)Study completedNCT05283057What this trial is testingEmpagliflozin in Patients With GlomerulonephritisWho this might be right forGlomerulonephritisProteinuria Kasr El Aini Hospital 50
Post-approval studies (Phase 4)Study completedNCT02700334What this trial is testingEffect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With PrediabetesWho this might be right forPrediabetesImpaired Fasting GlucoseImpaired Glucose Tolerance University of Guadalajara 24
Not applicableStudy completedNCT06432751What this trial is testingPre-operative Exposure to SGLT2 Inhibitors and Post-operative Acute Renal Failure in Cardiac SurgeryWho this might be right forAcute Kidney InjuryCardiac SurgerySodium/Glucose Cotransporter Inhibitor 2 Hospices Civils de Lyon 500
Early research (Phase 1)Study completedNCT03852901What this trial is testingSodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone ProductionWho this might be right forEmpaglifozinPhysiological Effects of DrugsHypoglycemic Agents+1 more National Institute on Aging (NIA) 21
Not applicableStudy completedNCT07022379What this trial is testingSodium-Glucose Cotransporter 2 Inhibitor Use in a National Heart Failure Telemonitoring ProgramWho this might be right forHeart FailureHeart Failure With Preserved Ejection Fraction (HFPEF)Heart Failure With Reduced Ejection Fraction+1 more Satelia 13,660
Post-approval studies (Phase 4)Looking for participantsNCT05672836What this trial is testingENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve ReplacementWho this might be right forAortic Valve StenosisHeart Failure Duk-Woo Park, MD 1,040
Large-scale testing (Phase 3)Not Yet RecruitingNCT07417306What this trial is testingHDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) InhibitorWho this might be right forType 2 Diabetes Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 912
Large-scale testing (Phase 3)Study completedNCT05676684What this trial is testingDapagliflozin With or Without Spironolactone for HFpEFWho this might be right forHeart Failure With Preserved Ejection Fraction Universidade do Porto 108